Fighting cancer with Silver & Light surgery

We eliminate cancer cell by cell, so it never returns.

We developed a new drug that is 6.000 times smaller than a human cell bypassing cell defense systems of a tumor cell. Once in the nucleus the drug is activated by light, causing a spike and resulting in cell death.

Grants & Loans Secured

Research Projects in Progress

Cancer Indications Targeted

We believe in a world where precision medicine can make cancer a treatable disease. Our mission is to close the gap in global cancer care by offering safe, effective, and complementary treatments to patients everywhere.

Why GenLumina?

Precision Oncology treatments are still limited due to off-target toxicity and bad tumor penetration.

Drug Design

We use DNA-encapsulated silver nanoclusters to create a drug small enough to enter tumor cell nuclei.

Activation Mechanism

Inside the tumor cell nucleus, the drug is activated by light, triggering a controlled toxic spike that directly attacks the cancer cell, leaving healthy tissues unharmed.

Safety and Efficacy

Our approach is less invasive, easing the burden on patients and healthcare systems.

Reduced Side Effects

Genlumina’s approach minimizes harm to healthy tissues, leading to fewer side effects and quicker recovery times for patients.

Integration and Scalability

Starting with skin cancer, our platform can expand to treat a wide range of cancers .

Learn more

Explore Our Technology

GenLumina’s innovation lies in our light-activated DNA nanotechnology. We create ultra-small packages to deliver a toxic payload directly into the cell nucleus. Using Two-Photon excitation, Spatial Light Modulation, and light-compatible needles, we activate the drug precisely at the tumor site.

Controlled and localised destruction

Treating cancer cells with unmatched accuracy, limiting side effects.

Compatibility with Existing Equipment

Scalable solutions using widely available surgical equipment in operating rooms.

Our technology doesn’t just treat cancer;
it’s designed to reshape we manage cancer globally.